Mill Capital Management’s Elevance Health ELV Stock Holding History

Mill Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.97M	Hold	10,142	–	–	0.23%	48
2025 Q4	$3.56M	Hold	10,142	–	–	0.26%	46
2025 Q3	$3.28M	Hold	10,142	–	–	0.24%	46
2025 Q2	$3.94M	Hold	10,142	–	–	0.31%	42
2025 Q1	$4.41M	Sell	10,142 -91	-0.9%	-$36.5K	0.35%	40
2024 Q4	$3.77M	Sell	10,233 -175	-2%	-$73.2K	0.3%	41
2024 Q3	$5.41M	Sell	10,408 -50	-0.5%	-$26.7K	0.42%	38
2024 Q2	$5.67M	Hold	10,458	–	–	0.47%	37
2024 Q1	$5.42M	Hold	10,458	–	–	0.45%	39
2023 Q4	$4.93M	Hold	10,458	–	–	0.44%	40
2023 Q3	$4.55M	Sell	10,458 -10	-0.1%	-$4.54K	0.45%	41
2023 Q2	$4.65M	Hold	10,468	–	–	0.44%	40
2023 Q1	$4.81M	Hold	10,468	–	–	0.49%	39
2022 Q4	$5.37M	Sell	10,468 -20	-0.2%	-$10.2K	0.59%	38
2022 Q3	$4.76M	Buy	10,488 +10	+0.1%	+$4.79K	0.56%	39
2022 Q2	$5.06M	Hold	10,478	–	–	0.56%	39
2022 Q1	$5.15M	Hold	10,478	–	–	0.49%	38
2021 Q4	$4.86M	Buy	+10,478	New	+$4.41M	0.5%	40

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Mill Capital Management's ELV Position: Q1 2026 in Review

Mill Capital Management held its Elevance Health (ELV) position steady in Q1 2026 at 10,142 shares worth $2.97M. The position accounts for 0.23% of the portfolio, ranked #48.

Mill Capital Management first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.67M in Q2 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Mill Capital Management held 10,142 shares of Elevance Health worth $2.97M as of Q1 2026.
Mill Capital Management left its Elevance Health share count unchanged in Q1 2026.
Elevance Health made up 0.23% of Mill Capital Management's portfolio in Q1 2026, its #48 holding.
Mill Capital Management first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
Mill Capital Management's Elevance Health position peaked at $5.67M in Q2 2024.
1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Mill Capital Management's 13F filing for Q1 2026, filed 4 May 2026.